Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 6/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11540502 | 1.00 | NAAA (0.50) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL7687966 | 1.00 | NAAA (0.50) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL9815160 | 1.00 | NAAA (0.50) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL9472810 | 1.00 | NAAA (0.50) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL11034348 | 0.98 | NAAA (0.47) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL455718 | 0.92 | ALDH1A1 (0.48) | NAAAHCAR2EPHX1TSHRALDH1A1 | |
| SCHEMBL7681788 | 0.90 | NAAA (0.55) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL7684054 | 0.90 | NAAA (0.55) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL7681798 | 0.90 | NAAA (0.55) | NAAAHCAR2EPHX1TSHRRAD52 | |
| SCHEMBL7687964 | 0.90 | NAAA (0.55) | NAAAHCAR2EPHX1TSHRRAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384279-B1 | OXIDIZING A DIAMIDODIOL TO FORM A DIACID FOLLOWED BY COUPLING WITH AN ARYL DIAMINE | THE CLOROX COMPANY | 2002-05-07 | — | — | US | disclosed |
| US-20020028970-A1 | SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | THE CLOROX COMPANY | 2002-03-07 | — | — | US | disclosed |
| US-6297400-B1 | CHELATING AGENTS FOR IMPROVED WASHFASTNESS OF DYE WHEN IN A BLEACHING ENVIRONMENT | THE CLOROX COMPANY | 2001-10-02 | — | — | US | disclosed |
| WO-2001002343-A1 | IMPROVED SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | THE CLOROX COMPANY (US) | 2001-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028970-A1 | SYNTHESIS OF A TETRAAMIDO MACROCYCLE LIGAND FROM A NOVEL DIAMIDODIOL | DDT, DDC, MLYCD | NAAA 2515/4885HCAR2 1572/4885EPHX1 2490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.